Proprietary intelligent polymer surface coating platform enables development of first-in-class lab materials for modern cell culture applications Closing of seed round completed raising €3.7 million from SARSTEDT, High-Tech Gründerfonds (HTGF), R3 Consulting, ARVE Capital, ROI Verwaltungsgesellschaft and Chemovator. faCellitate has developed an intelligent and ultra-low attachment polymer surface coating platform. The first launched product thereof is [...]

LAUSANNE, Switzerland and TEL AVIV, Israel – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, today announced a collaboration to accelerate the discovery of novel biomarkers and drug targets using the latest [...]

Previously CEO at Fendix, Mark‘s understanding of the wider medtech industry means he is well-placed to accelerate Zetta’s global momentum.  Zetta Genomics, a pioneer in large-scale genomic data management, has appointed Mark Bailey as its chief executive officer. Bailey has been brought in to lead Zetta’s next phase of growth. Ludo Chapman, Chair of Zetta Genomics, commented: “We welcome Mark’s [...]

PHILADELPHIA —Integral Molecular, the leader in antibody discovery against membrane proteins, has been accepted into the U.S. Food & Drug Administration (FDA)’s ISTAND pilot program. This program supports Innovative Science and Technology Approaches for New Drugs and was created to expand the drug development tool types listed in the 21st Century Cures legislation. A major goal [...]

Unterägeri, Switzerland _ SmartGene, a leading provider of bioinformatics Software-as-a-Service applications (SaaS Apps), today announced a new collaboration with Illumina, a global leader in DNA sequencing and array-based technologies, to enable broad adoption of Next Generation Sequencing (NGS) for routine analysis in infectious diseases and industrial markets. The scope of the collaboration includes clinical microbiology, food [...]

This partnership will use whole human genome sequencing to support actionable characterisation of rare genetic diseases.  Oxford Nanopore Technologies (Oxford Nanopore) and Al Jalila Children’s Specialty Hospital (AJCH) today announce a new partnership to investigate the potential utility of nanopore sequencing for children with unresolved rare genetic disorders. AJCH, the first and only dedicated children’s [...]

Qingdao, Shenzhen -- The 17th Annual Meeting of the International Conference on Genomics (ICG-17), a meeting point for leaders in the emerging field of Genomics to meet and share their experience and insights, is taking place on 5-7 September in Qingdao, China. At ICG-17, MGI introduces its mass production base of its latest miniaturized gene [...]

Alan Lockley joins as Director of Global Services, Edward Quinn as Director of Product Development and Mark Appleton takes new role as Director of Research London, UK -- H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimisation, safety, and scale-up, today announced three key appointments to the Company’s senior leadership [...]

Large multi-site COVID-19 study to use IsoPlexis Single Cell Functional Proteomics to survey immunity. BRANFORD, Conn. -- IsoPlexis (NASDAQ: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced a partnership with MediMergent, LLC, and The Center for Cancer and Blood Disorders (CCBD), an American Oncology Partners of [...]

SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN), today received a decision from the European Commission prohibiting the company's acquisition of GRAIL. The company is reviewing the Commission's order and intends to appeal the decision. The EC decision follows last week's ruling by US Federal Trade Commission judge in favor of Illumina's acquisition of GRAIL. "We are disappointed with [...]